Breakout Stocks

Results

96

82 new

Stocks where the price continues to rise after more than a year of consistent gains.

96 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	AU New	US$121.22	25.9%	122.0%	US$58.8b	US$113.13	16.3	13.1%	2.9%	Materials
	MRNA New	US$145.07	129.1%	434.9%	US$53.2b	US$91.39	26.0	56.9%	n/a	Pharmaceuticals & Biotech
	BNTX New	US$116.57	25.2%	5.1%	US$27.9b	US$121.48	9.5	14.3%	n/a	Pharmaceuticals & Biotech
	TWST New	US$145.59	22.8%	409.2%	US$8.5b	US$105.30	21.1	54.5%	n/a	Pharmaceuticals & Biotech
	AMLX New	US$38.66	78.7%	315.7%	US$4.4b	US$42.18	18.0	64.2%	n/a	Pharmaceuticals & Biotech
	RUM New	US$9.05	21.3%	17.2%	US$3.4b	US$22.00	30.8	83.5%	n/a	Media
	SLS New	US$15.46	21.0%	709.4%	US$2.7b	US$32.50	22.7	69.1%	n/a	Pharmaceuticals & Biotech
	DRD New	US$30.70	26.9%	78.5%	US$2.6b	US$35.00	10.0	8.1%	3.5%	Materials
	AMR New	US$210.01	26.5%	48.5%	US$2.5b	US$168.33	1.3	99.9%	0%	Materials
	MRVI New	US$8.64	51.6%	252.7%	US$2.2b	US$7.30	6.2	24.8%	n/a	Pharmaceuticals & Biotech
	PSNL New	US$18.38	30.9%	280.5%	US$1.8b	US$13.88	28.2	15.7%	n/a	Pharmaceuticals & Biotech
	TOP New	US$14.13	27.0%	139.5%	US$1.6b	n/a	391.3	n/a	0%	Diversified Financials
	TINV	US$36.50	247.3%	261.0%	US$1.3b	n/a	-151.2	n/a	n/a	Diversified Financials
	IMMX New	US$13.66	24.5%	523.7%	US$941.5m	US$20.28	4.3	45.8%	n/a	Pharmaceuticals & Biotech
	FDMT New	US$15.83	29.9%	123.3%	US$889.4m	US$29.10	9.5	6.0%	n/a	Pharmaceuticals & Biotech
	NVCT New	US$23.56	24.3%	242.9%	US$760.8m	US$34.20	84.5	43.2%	n/a	Pharmaceuticals & Biotech
	SGLA	US$6.00	89.9%	200.0%	US$684.0m	n/a	597.5	n/a	n/a	Commercial Services
	OABI New	US$4.33	28.1%	134.1%	US$625.2m	US$7.67	16.4	53.2%	n/a	Pharmaceuticals & Biotech
	CTNM New	US$17.19	21.1%	72.9%	US$602.7m	US$23.43	2.7	46.3%	n/a	Pharmaceuticals & Biotech
	SENS New	US$9.71	24.3%	6.1%	US$466.3m	US$13.40	10.6	22.6%	n/a	Healthcare
	MTHI New	US$3.00	71.4%	329.8%	US$374.0m	n/a	n/a	n/a	n/a	Capital Goods
	SMIH	US$13.00	31.2%	33.9%	US$334.8m	n/a	19.0	n/a	n/a	Diversified Financials
	OBIO New	US$5.36	21.5%	110.2%	US$326.4m	US$12.33	10.1	32.2%	n/a	Healthcare
	PRQR New	US$2.34	21.9%	3.5%	US$320.3m	US$8.22	15.3	5.1%	n/a	Pharmaceuticals & Biotech

Page 1 of 3